Etirinotecan pegol in women with recurrent platinum-resistant or refractory ovarian cancer

Bardhi, E; Marchetti, C; Scopelliti, A; Musacchio, L; Tomao, F; Schiavi, M; Carraro, C; Palaia, I; Monti, M; Muzii, L; Panici, PB

Marchetti, C (reprint author), Sapienza Univ Rome, Dept Gynecol Obstet Sci & Urol Sci, Viale Policlin 155, I-00161 Rome, Italy.

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019; 28 (8): 667